Biotech · Private company
Ashibio Inc
Track this companyFree. Adds Ashibio Inc to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- AndecaliximabPhase 3 · Fibrodysplasia Ossificans ProgressivaClinicalTrials.gov · fetched Nov 12, 2026
- AndecaliximabPhase 2 · Heterotopic Ossification (HO)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 14, 2025ClinicalTrials.gov NCT07024407 · fetched Nov 12, 2026
- A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 25, 2024ClinicalTrials.gov NCT06508021 · fetched Nov 12, 2026